BIVDA is a member of the Life Sciences TAG. Due to the very confidential nature of the discussions, members are required to hold a personal non-disclosure agreement and are restricted on what may be shared until formalised. Helen and Doris-Ann have these in place.
This enables frank conversations about the negotiations and crucially where different parts of the sector have differing requirements. It is a testing ground for trade deals and the WTO and has been highly active with regard to vaccine and technology exports, but therapeutics and Diagnostics are also in scope.
The role of the group is to co-ordinate different officials working on the trade discussions around IP, WTO and Policy and sector specific issues.
The key high-level/ generic/ non-specific messages that were discussed in a 1-1 last week with TAG as important to members are;
- Global companies need to be able to import into the UK easily.
- Domestic suppliers need to be able to export into any market easily which is currently challenging, and the UK is not attractive to set up business at present.
- SME’s need to be able to import and export easily with minimum barriers.
- The priority is for UK patients to receive the best technology, products and treatments and the current environment favours products being launched in other countries and affects the affordability for the NHS.
- Animal by-products and chemicals need to be considered for IVD manufacturers and importers and quality obligations placed on the UK cannot be undermined by different quality requirements allowed on import from other countries.
The Department of Business and Trade does a monthly External Affairs call which BIVDA attends and the information in that call can be shared with members and usually features in BIVDA’s External Affairs working party or newsletter. If members have any specific questions that they want to ask, please contact Helen or Ben.